Health agencies will share cancer drug data

Health agencies will share cancer drug data

The Food and Drug Administration and the National Cancer Institute are teaming to up to build a grid-computing system that will let drug researchers share developmental data about cancer drugs.

The initiative will let researchers electronically submit applications to investigate new drugs, FDA commissioner Mark McClellan said. It also will give cancer researchers online access to FDA’s drug review databases, letting them access and evaluate clinical trial data, he said.

The effort is part of the cancer institute’s broader online initiative, the Cancer Biomedical Informatics Grid Project.

McClellan described the data-sharing project yesterday at a meeting of the President’s Information Technology Advisory Committee in Arlington, Va.

The project sprang from an interagency task force formed in May to study ways to expedite the review process for new cancer drugs.

For more information about the grid project, click on caBIG site.

About the Author

Connect with the GCN staff on Twitter @GCNtech.

Featured

  • Contracting
    8 prototypes of the border walls as tweeted by CBP San Diego

    DHS contractors face protests – on the streets

    Tech companies are facing protests internally from workers and externally from activists about doing for government amid controversial policies like "zero tolerance" for illegal immigration.

  • Workforce
    By Mark Van Scyoc Royalty-free stock photo ID: 285175268

    At OPM, Weichert pushes direct hire, pay agent changes

    Margaret Weichert, now acting director of the Office of Personnel Management, is clearing agencies to make direct hires in IT, cyber and other tech fields and is changing pay for specialized occupations.

  • Cloud
    Shutterstock ID ID: 222190471 By wk1003mike

    IBM protests JEDI cloud deal

    As the deadline to submit bids on the Pentagon's $10 billion, 10-year warfighter cloud deal draws near, IBM announced a legal protest.

Stay Connected

FCW Update

Sign up for our newsletter.

I agree to this site's Privacy Policy.